Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Treasury Shares (2021 - 2025)

RxSight filings provide 4 years of Treasury Shares readings, the most recent being $585458.0 for Q4 2024.

  • On a quarterly basis, Treasury Shares fell 9.98% to $585458.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $585458.0, a 9.98% decrease, with the full-year FY2024 number at $585458.0, down 9.98% from a year prior.
  • Treasury Shares hit $585458.0 in Q4 2024 for RxSight, down from $650357.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $650357.0 in Q4 2023 to a low of $492862.0 in Q4 2022.
  • Median Treasury Shares over the past 4 years was $612968.5 (2021), compared with a mean of $592289.0.
  • Biggest five-year swings in Treasury Shares: dropped 23.05% in 2022 and later soared 31.96% in 2023.
  • RxSight's Treasury Shares stood at $640479.0 in 2021, then fell by 23.05% to $492862.0 in 2022, then surged by 31.96% to $650357.0 in 2023, then dropped by 9.98% to $585458.0 in 2024.
  • The last three reported values for Treasury Shares were $585458.0 (Q4 2024), $650357.0 (Q4 2023), and $492862.0 (Q4 2022) per Business Quant data.